Harold Brakewood
Fortune : 63 758 $ au 31/05/2026
Fortune : 63 758 $ au 31/05/2026
Harold E.
Brakewood is Chief Business Officer at Immuneering Corp.
since 2023.
From 2015 to 2021, served as Vice President & Head-Oncology Business Unit at Regeneron Pharmaceuticals, Inc. Education includes undergraduate degree from Bowdoin College, graduate degree from Dartmouth College, and MBA from Harvard Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/02/2026 | 11 050 ( 0,02 % ) | 63 759 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNEERING CORPORATION | Corporate Officer/Principal | 28/03/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bowdoin College
Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national